Clinical trial

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

NCT05332340

Study summary

ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention BZ371A Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-11-16

PhasePHASE1

Conditions

Erectile Dysfunction Following Radical Prostatectomyunresolved

Erectile Dysfunctionverified · MONDO: erectile dysfunction

Prostate Cancerverified · MONDO: prostate cancer

Radical Prostatectomyunresolved

Interventions

BZ371ADRUG

Sponsors & collaborators

Biozeus Biopharmaceutical S.A.lead sponsor

Azidus Brasil Scientific Research and Development Ltdacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05332340 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.